Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Infection
46%
Chikungunya Virus
44%
Chikungunya
27%
Disease
24%
Ebola Virus
21%
Arthritis
19%
Ethanol
16%
Coronavirinae
14%
Adenosine Phosphate
14%
Injury
14%
Polypeptide Antibiotic Agent
13%
Antivirus Agent
11%
Virus Infection
10%
Pathophysiology
10%
Virus RNA
10%
Amino Acid
10%
Antiviral Activity
9%
Synthetase
9%
Western Blot
9%
microRNA
9%
Mouse Model
9%
Malonaldehyde
9%
Bone Defect
9%
Protein Binding
9%
Cigarette Smoke
9%
Cross Sectional Study
9%
Rat Model
9%
Cyclic GMP
9%
Surfactant Protein D
9%
Cathelicidin
9%
Repurposing
9%
Strontium Ranelate
9%
Metabolic Disorder
9%
Transmission Electron Microscopy
9%
Apabetalone
9%
Sphingosine Kinase 2
9%
Interferon Type I
9%
Nanofiber
9%
Fibrosis
9%
Chronic Obstructive Lung Disease
9%
Sphingosine Kinase Inhibitor
9%
Artemisinin
9%
Antimalarial Agent
9%
Resveratrol
9%
Kenpaullone
9%
Epileptic Absence
9%
Filovirus
9%
Fatality
9%
Interferon
9%
Immunology and Microbiology
Ebola Virus
75%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
COVID-19
43%
Viral Disease
35%
Chikungunya Virus
27%
interferon
26%
Viral Replication
22%
STAT1
18%
Neutrophil Granulocyte
15%
Vaccine Efficacy
14%
Marburgvirus
12%
Beta Interferon
11%
Neutrophil
10%
Filovirus
10%
Zika Virus
9%
Degranulation
9%
Adduction
9%
Virus Neutralization
9%
Rhesus Monkey
9%
Surfactant Protein D
9%
Transcription Factor Nrf2
9%
Epigenetics
9%
Antimicrobial Peptides
9%
Nucleoprotein
9%
Cathelicidin
9%
Spike
9%
DNA Methylation
9%
Secretion (Process)
9%
Intravenous Immunoglobulin
9%
Protein Binding
9%
Lymphocyte Count
9%
Regulatory T Cell
9%
Matrix Protein
9%
Guinea Pig
9%
Glycosylation
9%
Pathogenic Potential
9%
Stimulator of Interferon Genes
9%
VP40
9%
Surface Property
9%
Viral Pathogenesis
8%
Host Cell
8%
Coronavirinae
7%
Viral Protein
6%
Wild Type
6%
RNA Binding
6%
Keyphrases
Ebola Virus
27%
COVID-19
27%
Chikungunya Virus (CHIKV)
23%
Karyopherin
22%
Aerosol Contamination
18%
Bone Pathology
15%
VP24
13%
Chikungunya Virus Infection
12%
VP24 Protein
12%
Phosphorylated STAT1
11%
Ebola Virus Infection
11%
Nuclear Accumulation
9%
AR-12
9%
Human Bronchial Epithelial Cells
9%
Porous Liquids
9%
Leakage Resistance
9%
MicroRNA
9%
Test Sensitivity
9%
Acute Arthritis
9%
RUVBL2
9%
Unconventional Secretion
9%
Nanofibers
9%
Pathophysiology
9%
Bronchial Epithelial Cells
9%
Interferon Antagonist
9%
Cigarette Smoking
9%
Chronic chikungunya Arthritis
9%
Arboviral Infection
9%
Sars-cov-2 Infection
9%
Apabetalone
9%
Chronic Knee Pain
9%
Cathelicidin Antimicrobial Peptide
9%
SARS-CoV-2 Aerosols
9%
Culturability
9%
HSPA5
9%
Mouse Model
9%
Skotomorphogenesis
9%
Surface Contamination
9%
Sphingosine Kinase Inhibitor
9%
Detrimental Effects
9%
Alcohol
9%
Human-driven
9%
Immuno-epidemiology
9%
Cynarin
9%
Characteristic Direction
9%
L1000
9%
Library of Integrated Network-based Cellular Signatures
9%
Biological Specimens
9%
Post-acute
9%
Artemisinin Antimalarial
9%